IRF1 and myeloid sarcoma: The transcription factor interferon regulatory factor 1 (IRF-1) has also been implicated in the pathogenesis of EAE and MS, and transgenic mice with suppressed IRF-1 specifically in oligodendrocytes are protected against EAE and show decreased inflammatory demyelination, as well as oligodendrocyte and axonal preservation.